(19)
(11) EP 1 438 043 A2

(12)

(88) Date of publication A3:
24.12.2003

(43) Date of publication:
21.07.2004 Bulletin 2004/30

(21) Application number: 02790295.6

(22) Date of filing: 17.10.2002
(51) International Patent Classification (IPC)7A61K 31/403, A61P 1/18, A61P 3/10, A61P 5/50, A61K 38/55, A61K 31/00
(86) International application number:
PCT/EP2002/011636
(87) International publication number:
WO 2003/032963 (24.04.2003 Gazette 2003/17)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 17.10.2001 US 344495 P

(71) Applicant: Aventis Pharma Deutschland GmbH
65929 Frankfurt am Main (DE)

(72) Inventor:
  • YUSUF, Salim
    Carlisle, Ontario L0R 1H2 (CA)

   


(54) METHOD OF REDUCING TYPE 2 DIABETES IN HIGH RISK PATIENTS